David Einhorn – TEVA history
- Issuer:
- TEVA PHARMACEUTICAL INDS LTD
- Quarters tracked:
- 10 (Q4 2023 → Q1 2026)
- Current shares:
- 2,910,729
- Current value:
- $87.67M
- Peak shares:
- 3,778,777 (Q2 2025)
- Overall change:
- +984%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 2,910,729 | $87.67M | $30.12 | -148,005 | -5% |
| Q4 2025 | 3,058,734 | $95.46M | $31.21 | -720,043 | -19% |
| Q3 2025 | 3,778,777 | $76.33M | $20.20 | 0 | 0% |
| Q2 2025 | 3,778,777 | $63.33M | $16.76 | +3,210,577 | +565% |
| Q1 2025 | 568,200 | $8.73M | $15.37 | +99,650 | +21% |
| Q4 2024 | 468,550 | $10.33M | $22.04 | +143,700 | +44% |
| Q3 2024 | 324,850 | $5.85M | $18.02 | 0 | 0% |
| Q2 2024 | 324,850 | $5.28M | $16.25 | 0 | 0% |
| Q1 2024 | 324,850 | $4.58M | $14.11 | +56,380 | +21% |
| Q4 2023 | 268,470 | $2.80M | $10.44 | — | NEW |